Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Asian Spine Journal ; : 553-557, 2016.
Artículo en Inglés | WPRIM | ID: wpr-160171

RESUMEN

A 43-year-old male patient with C5 giant cell tumor (GCT) underwent tumor resection and anterior bone fusion of C4-C6. The tumor recurred locally 9 months after surgery with the patient complaining of neck and shoulder pain similar to his preoperative symptoms. Denosumab was administered and his pain disappeared after a two-month administration, with a sclerotic rim formation seen at the tumor site on computed tomography. He has been followed for 18 months with no evidence of tumor recurrence. Complete resection is generally recommended, but is not easy for many patients with cervical GCT because of the existence of neurovascular structures. Some patients suffer from recurrence and treatment becomes more difficult. As such, denosumab may be an efficacious option for treatment of recurrent GCT of the cervical spine, although long-term follow-up is required to monitor for presence or absence of recurrence.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Vértebras Cervicales , Denosumab , Estudios de Seguimiento , Tumor Óseo de Células Gigantes , Tumores de Células Gigantes , Cuello , Recurrencia , Dolor de Hombro , Columna Vertebral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA